DEERFIELD, Sick., July 20, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a worldwide medical expertise firm targeted on elevating the usual of care by driving the evolution of digital well being, at present introduced the industrial relaunch of its CervAlign® anterior cervical plate (ACP) system. This subsequent era plate design comes with an enhanced locking system design and enhances the Firm’s place in one of many largest procedural classes in backbone—the anterior cervical discectomy and fusion (ACDF) market.
“We’re completely happy to introduce an improved model of CervAlign ACP after an prolonged interval of restricted availability of one in every of our flagship merchandise,” acknowledged Terry Wealthy, President and Chief Government Officer of Surgalign. “We took the previous 12 months to judge the wants of the market and we’re excited to convey the CervAlign plate again as we proceed to drive higher affected person outcomes. Whereas this finally hindered our 2021 outcomes, it was the prudent transfer and in the most effective pursuits of our clients and sufferers who depend on our expertise.”
The CervAlign system is designed for a number of ACDF procedural options as it could possibly accommodate semi-constrained, constrained and hybrid constructs for one- to five-level anterior cervical fusions. The plate includes a 2.2mm minimal profile with zero-profile locking designed to attenuate tissue disruption and problems, equivalent to dysphasia.
“I’m very happy with the design of the subsequent era CervAlign ACP system and am assured the brand new providing will result in improved scientific efficiency,” stated Vittorio Morreale, MD, and Director of Neurosurgery at Henry Ford Macomb Hospital in Michigan. “The plate has a bolstered locking mechanism whereas retaining the aggressive low-profile design, and I imagine it’s an incredible resolution for my cervical sufferers.”
Initially launched to the market in 2019, the CervAlign system was one of many Firm’s quickest rising product traces. The following era plate design provides to the Firm’s already strong ACDF portfolio, which additionally contains Fortilink® interbody options with TiPlus™ and TETRAfuse® applied sciences, Unison®-C standalone interbody, and extra plating options. The anterior cervical portfolio is complemented by the Firm’s posterior cervical options, which embrace Streamline® OCT, one of many lowest-profile posterior cervical fixation techniques in the marketplace, and the Launch® laminoplasty system.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a worldwide medical expertise firm dedicated to the promise of digital well being to drive transformation throughout the surgical panorama. Uniquely aligned and resourced to advance the usual of care, the corporate is constructing applied sciences physicians and different well being suppliers will look to for what is really attainable for his or her sufferers. Surgalign is concentrated on creating options that predictably ship superior scientific and financial outcomes. Surgalign markets merchandise all through the US and in additional than 50 nations worldwide by means of an increasing community of high impartial distributors. Surgalign is headquartered in Deerfield, IL, with industrial, innovation and design facilities in San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Be taught extra at www.surgalign.com and join on LinkedIn and Twitter.
Ahead Wanting Assertion
This press launch comprises forward-looking statements throughout the which means of the Personal Securities Litigation Reform Act of 1995. These forward-looking statements are primarily based on administration’s present expectations, estimates and projections about our merchandise, firm, and trade, our administration’s beliefs, and sure assumptions made by our administration. Phrases equivalent to “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and different variations of such phrases and comparable expressions are meant to determine such forward-looking statements. These statements will not be ensures of future efficiency and are topic to dangers and uncertainties, together with the dangers described in our public filings with the U.S. Securities and Trade Fee (SEC). Our precise outcomes could differ materially from the anticipated outcomes mirrored in these forward-looking statements. Copies of the corporate’s SEC filings could also be obtained by contacting the corporate or the SEC or by visiting Surgalign’s web site at www.surgalign.com or the SEC’s web site at www.sec.gov.